Your browser doesn't support javascript.
loading
Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy.
Kruit, W H J; Stoter, G; Klijn, J G M.
Affiliation
  • Kruit WH; Department of Medical Oncology, Daniel den Hoed Cancer Center, Erasmus Medical Center, Rotterdam, The Netherlands. w.kruit@erasmusmc.nl
Anticancer Drugs ; 15(9): 843-7, 2004 Oct.
Article in En | MEDLINE | ID: mdl-15457124
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Prostate-Specific Antigen / Antineoplastic Agents, Hormonal Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2004 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Prostate-Specific Antigen / Antineoplastic Agents, Hormonal Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2004 Document type: Article Affiliation country: Country of publication: